相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial
Domenica M. Rubino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague
Dung Nguyen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
A population physiologically-based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab
Hsuan Ping Chang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Physiological based pharmacokinetic and biopharmaceutics modelling of subcutaneously administered compounds - An overview of in silico models
Ilse R. Dubbelboer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Use of a physiologically based pharmacokinetic-pharmacodynamic model for initial dose prediction and escalation during a paediatric clinical trial
Trevor N. Johnson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Are body surface area based estimates of liver volume applicable to children with overweight or obesity? An in vivo validation study
Chelsea Hosey-Cojocari et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Safety of Semaglutide
Mark M. Smits et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Model-Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes
Heeseung Jo et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2021)
Modern pharmacological treatment of obese patients
Marcus May et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2020)
Physiologically-based pharmacokinetic models for children: Starting to reach maturation?
Laurens F. M. Verscheijden et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Development of a physiologically based pharmacokinetic model for mefloquine and its application alongside a clinical effectiveness model to select an optimal dose for prevention of malaria in young Caucasian children
Trevor N. Johnson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Children and Adolescents: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the US Food and Drug Administration's Office of Clinical Pharmacology
Manuela Grimstein et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Application of Physiologically-Based and Population Pharmacokinetic Modeling for Dose Finding and Confirmation During the Pediatric Development of Moxifloxacin
Stefan Willmann et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Exposure-response analysis for evaluation of semaglutide dose levels in type 2 diabetes
Kristin C. C. Petri et al.
DIABETES OBESITY & METABOLISM (2018)
Change in Overweight from Childhood to Early Adulthood and Risk of Type 2 Diabetes
Lise G. Bjerregaard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability
A. K. J. Gradel et al.
JOURNAL OF DIABETES RESEARCH (2018)
Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species
Lene Jensen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes A Randomized Clinical Trial
Melanie Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Central aortic pressure, arterial stiffness and echocardiographic parameters of children with overweight/obesity and arterial hypertension
Jerzy Wojtowicz et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2017)
Diabetes complications in childhood and adolescent onset type 2 diabetes-a review
Anandakumar Amutha et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Childhood Obesity Associates Haemodynamic and Vascular Changes That Result in Increased Central Aortic Pressure with Augmented Incident and Reflected Wave Components, without Changes in Peripheral Amplification
Juan M. Castro et al.
INTERNATIONAL JOURNAL OF VASCULAR MEDICINE (2016)
Modeling and Simulation in Pediatric Drug Therapy: Application of Pharmacometrics to Define the Right Dose for Children
A. A. Vinks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification
Jennifer E. Sager et al.
DRUG METABOLISM AND DISPOSITION (2015)
Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
David J. Klein et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2014)
Challenging Recruitment of Youth With Type 2 Diabetes Into Clinical Trials
Tammy T. Nguyen et al.
JOURNAL OF ADOLESCENT HEALTH (2014)
Glomerular Filtration Rate and Cardiometabolic Risk in an Outpatient Pediatric Population with High Prevalence of Obesity
Procolo Di Bonito et al.
OBESITY (2014)
Childhood Obesity Impact on Cardiac Geometry and Function
Norman Mangner et al.
JACC-CARDIOVASCULAR IMAGING (2014)
Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
A. R. Maharaj et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Prevalence of hypertension and decreased glomerular filtration rate in obese children: results of a population-based field study
Ali Duzova et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Regulatory Experience With Physiologically Based Pharmacokinetic Modeling for Pediatric Drug Trials
R. Leong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Best Practice in the Use of Physiologically Based Pharmacokinetic Modeling and Simulation to Address Clinical Pharmacology Regulatory Questions
P. Zhao et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
ELEVATED AMYLASE AND LIPASE LEVELS IN PATIENTS USING GLUCAGONLIKE PEPTIDE-1 RECEPTOR AGONISTS OR DIPEPTIDYL-PEPTIDASE-4 INHIBITORS IN THE OUTPATIENT SETTING
Howard M. Lando et al.
ENDOCRINE PRACTICE (2012)
Dosing Rationale for Liraglutide in Type 2 Diabetes Mellitus: A Pharmacometric Assessment
Steen H. Ingwersen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
DrugBank: a comprehensive resource for in silico drug discovery and exploration
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2006)
分享论文
